{"id":2775,"date":"2016-09-04T06:52:26","date_gmt":"2016-09-04T06:52:26","guid":{"rendered":"https:\/\/negargetni.com\/?p=2775"},"modified":"2024-09-04T08:53:04","modified_gmt":"2024-09-04T08:53:04","slug":"presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague","status":"publish","type":"post","link":"https:\/\/integragen.com\/en\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/","title":{"rendered":"PRESENTATION OF NEW RESULTS ON THE MIR-31-3P BIOMARKER IN AN ORAL PRESENTATION AT THE ESMO 2016 CONGRESS IN COPENHAGEN"},"content":{"rendered":"<p>The results of new analyses carried out on the FIRE-3 trial concerning the predictive role of the mir-31-3p marker in metastatic colorectal cancer will be presented at the 2016 congress of the European Society of Medical Oncology (ESMO) to be held in Copenhagen from October 7 to 12.<\/p>\n\n\n\n<p>Professor Pierre Laurent-Puig, MD, PhD, Physician at the Biochemistry Department of the Georges Pompidou European Hospital (Paris) and Director of the Inserm UMR-S775 research unit at the Paris Descartes University of Medicine, will detail these new findings on the ability of miR-31-3p to predict response to Cetuximab treatment during a proffered session on Monday October 10 at 9:15 (Copenhagen Room, North Hall of the Bella Center).<\/p>\n\n\n\n<p id=\"tw-target-text\"><strong>Click here for more details:<\/strong>&nbsp;<a href=\"https:\/\/cslide.ctimeetingtech.com\/library\/esmo\/browse\/search\/Htr\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/cslide.ctimeetingtech.com\/library\/esmo\/browse\/search\/Htr<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The results of new analyses carried out on the FIRE-3 trial relating to the predictive role of the mir-31-3p marker in metastatic colorectal cancer will be presented at the 2016 congress of the European Society of Medical Oncology (ESMO) to be held in Copenhagen from October 7 to 12. Professor Pierre Laurent-Puig, MD, PhD, Physician in the Department of...<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ca_portfolio_gallery_project_year":"","ca_portfolio_gallery_client":"","ca_portfolio_gallery_skills":"","ca_portfolio_gallery_url":"","ca_portfolio_gallery_images":"","_eb_attr":"","footnotes":""},"categories":[5,1],"tags":[],"class_list":["post-2775","post","type-post","status-publish","format-standard","hentry","category-actualite","category-toutes-les-categories"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L&#039;ESMO 2016 \u00c0 COPENHAGUE<\/title>\n<meta name=\"description\" content=\"Les r\u00e9sultats de nouvelles analyses r\u00e9alis\u00e9es sur l\u2019essai FIRE-3 relatives au r\u00f4le pr\u00e9dictif du marqueur mir-31-3p dans le cancer colorectal m\u00e9tastatique\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/integragen.com\/en\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L&#039;ESMO 2016 \u00c0 COPENHAGUE\" \/>\n<meta property=\"og:description\" content=\"Les r\u00e9sultats de nouvelles analyses r\u00e9alis\u00e9es sur l\u2019essai FIRE-3 relatives au r\u00f4le pr\u00e9dictif du marqueur mir-31-3p dans le cancer colorectal m\u00e9tastatique\" \/>\n<meta property=\"og:url\" content=\"https:\/\/integragen.com\/en\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/\" \/>\n<meta property=\"og:site_name\" content=\"IntegraGen\" \/>\n<meta property=\"article:published_time\" content=\"2016-09-04T06:52:26+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-04T08:53:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/integragen.com\/wp-content\/uploads\/2024\/07\/image-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2478\" \/>\n\t<meta property=\"og:image:height\" content=\"684\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"marine Deruy\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"marine Deruy\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/\"},\"author\":{\"name\":\"marine Deruy\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f7984826e661ce0b8d186cd690160607\"},\"headline\":\"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L&rsquo;ESMO 2016 \u00c0 COPENHAGUE\",\"datePublished\":\"2016-09-04T06:52:26+00:00\",\"dateModified\":\"2024-09-04T08:53:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/\"},\"wordCount\":175,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"articleSection\":[\"Actualit\u00e9s\",\"Toutes les Cat\u00e9gories\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/\",\"name\":\"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L'ESMO 2016 \u00c0 COPENHAGUE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\"},\"datePublished\":\"2016-09-04T06:52:26+00:00\",\"dateModified\":\"2024-09-04T08:53:04+00:00\",\"description\":\"Les r\u00e9sultats de nouvelles analyses r\u00e9alis\u00e9es sur l\u2019essai FIRE-3 relatives au r\u00f4le pr\u00e9dictif du marqueur mir-31-3p dans le cancer colorectal m\u00e9tastatique\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/integragen.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\\\/\\\/integragen.com\\\/actualite\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L&rsquo;ESMO 2016 \u00c0 COPENHAGUE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"name\":\"IntegraGen - Clinical Genomic Experts\",\"description\":\"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CRO\",\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"alternateName\":\"IntegraGen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/integragen.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\",\"name\":\"IntegraGen\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"contentUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"width\":2478,\"height\":684,\"caption\":\"IntegraGen\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/integragen\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f7984826e661ce0b8d186cd690160607\",\"name\":\"marine Deruy\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5685106104a4c5e6743b91f64c795a73a59ee61d6ed874b92a492380bb90952c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5685106104a4c5e6743b91f64c795a73a59ee61d6ed874b92a492380bb90952c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/5685106104a4c5e6743b91f64c795a73a59ee61d6ed874b92a492380bb90952c?s=96&d=mm&r=g\",\"caption\":\"marine Deruy\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L'ESMO 2016 \u00c0 COPENHAGUE","description":"Les r\u00e9sultats de nouvelles analyses r\u00e9alis\u00e9es sur l\u2019essai FIRE-3 relatives au r\u00f4le pr\u00e9dictif du marqueur mir-31-3p dans le cancer colorectal m\u00e9tastatique","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/integragen.com\/en\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/","og_locale":"en_US","og_type":"article","og_title":"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L'ESMO 2016 \u00c0 COPENHAGUE","og_description":"Les r\u00e9sultats de nouvelles analyses r\u00e9alis\u00e9es sur l\u2019essai FIRE-3 relatives au r\u00f4le pr\u00e9dictif du marqueur mir-31-3p dans le cancer colorectal m\u00e9tastatique","og_url":"https:\/\/integragen.com\/en\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/","og_site_name":"IntegraGen","article_published_time":"2016-09-04T06:52:26+00:00","article_modified_time":"2024-09-04T08:53:04+00:00","og_image":[{"width":2478,"height":684,"url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/07\/image-1.png","type":"image\/png"}],"author":"marine Deruy","twitter_card":"summary_large_image","twitter_misc":{"Written by":"marine Deruy","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/#article","isPartOf":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/"},"author":{"name":"marine Deruy","@id":"https:\/\/integragen.com\/#\/schema\/person\/f7984826e661ce0b8d186cd690160607"},"headline":"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L&rsquo;ESMO 2016 \u00c0 COPENHAGUE","datePublished":"2016-09-04T06:52:26+00:00","dateModified":"2024-09-04T08:53:04+00:00","mainEntityOfPage":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/"},"wordCount":175,"commentCount":0,"publisher":{"@id":"https:\/\/integragen.com\/#organization"},"articleSection":["Actualit\u00e9s","Toutes les Cat\u00e9gories"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/","url":"https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/","name":"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L'ESMO 2016 \u00c0 COPENHAGUE","isPartOf":{"@id":"https:\/\/integragen.com\/#website"},"datePublished":"2016-09-04T06:52:26+00:00","dateModified":"2024-09-04T08:53:04+00:00","description":"Les r\u00e9sultats de nouvelles analyses r\u00e9alis\u00e9es sur l\u2019essai FIRE-3 relatives au r\u00f4le pr\u00e9dictif du marqueur mir-31-3p dans le cancer colorectal m\u00e9tastatique","breadcrumb":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/integragen.com\/toutes-les-categories\/presentation-de-nouveauc-resultats-sur-le-biomarqueur-mir-31-3p-en-presentation-orale-au-congres-de-lesmo-2016-a-copenhague\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/integragen.com\/"},{"@type":"ListItem","position":2,"name":"Actualit\u00e9s","item":"https:\/\/integragen.com\/actualite\/"},{"@type":"ListItem","position":3,"name":"PR\u00c9SENTATION DE NOUVEAU RESULTATS SUR LE BIOMARQUEUR MIR-31-3P EN PR\u00c9SENTATION ORALE AU CONGR\u00c8S DE L&rsquo;ESMO 2016 \u00c0 COPENHAGUE"}]},{"@type":"WebSite","@id":"https:\/\/integragen.com\/#website","url":"https:\/\/integragen.com\/","name":"IntegraGen - Clinical Genomic Experts","description":"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CROs","publisher":{"@id":"https:\/\/integragen.com\/#organization"},"alternateName":"IntegraGen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/integragen.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/integragen.com\/#organization","name":"IntegraGen","url":"https:\/\/integragen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/","url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","contentUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","width":2478,"height":684,"caption":"IntegraGen"},"image":{"@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/integragen\/"]},{"@type":"Person","@id":"https:\/\/integragen.com\/#\/schema\/person\/f7984826e661ce0b8d186cd690160607","name":"marine Deruy","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/5685106104a4c5e6743b91f64c795a73a59ee61d6ed874b92a492380bb90952c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/5685106104a4c5e6743b91f64c795a73a59ee61d6ed874b92a492380bb90952c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5685106104a4c5e6743b91f64c795a73a59ee61d6ed874b92a492380bb90952c?s=96&d=mm&r=g","caption":"marine Deruy"}}]}},"_links":{"self":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2775","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/comments?post=2775"}],"version-history":[{"count":2,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2775\/revisions"}],"predecessor-version":[{"id":2793,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2775\/revisions\/2793"}],"wp:attachment":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/media?parent=2775"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/categories?post=2775"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/tags?post=2775"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}